Inhalant Abuse: Supporting Broad-Based Research Approaches (R21)

The summary for the Inhalant Abuse: Supporting Broad-Based Research Approaches (R21) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Inhalant Abuse: Supporting Broad-Based Research Approaches (R21): -The goal of this funding opportunity announcement (FOA) is to encourage research on all aspects of inhalant abuse (i.e., epidemiology; prevention, treatment and service delivery; antecedents, consequences and neurobiological mechanisms). -Inhalants are volatile substances that produce chemical vapors that can be inhaled to induce a psychoactive or mind-altering effect. Prevalence data indicate that inhalant abuse continues to be a major public health concern among grade school children, adolescents and some adults. Inhalants pose a particular hazard since they are readily accessible, legal and inexpensive. They often are abused by young children and can be highly toxic or lethal. The National Institute on Drug Abuse (NIDA) invites qualified researchers to submit research grant applications aimed at improving our understanding of inhalant abuse, particularly among pre-adolescent and adolescent populations. -Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. -The total project period for an application submitted in response to this funding opportunity may not exceed two years. Direct costs are limited to $275,000 over an R21 two-year period, with no more than $200,000 in direct costs allowed in any single year. -This funding opportunity will use the R21 mechanism, but will run in parallel with two FOAs of identical scientific scope (PA-05-099) that will utilize the traditional research project grant (R01) or (PA-06-328) the small grant (R03) mechanism. -Eligible organizations include for-profit or non-profit organizations, public or private institutions (e.g., universities, colleges, hospitals and laboratories), units of State and local government, eligible agencies of the Federal government, domestic or foreign institutions/organizations, and faith-based or community-based organizations, and units of state and local tribal governments. -Eligible Project Directors/Principal Investigators (PD/PIs): Any individual with the skills, knowledge, and resources necessary to carry out the proposed research is invited to work with their institution to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. -Applicants may submit more than one application, provided each application is scientifically distinct.